Recruiting Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST NCT06735820 Conditions Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +24 more Locations Children's National Hospital — Washington D.C., District of Columbia, United States UT Southwestern Medical Center — Dallas, Texas, United States View Trial Details
Recruiting Neurofibromatosis Type 1 Tumor Early Detection Study NCT06515860 Conditions Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +28 more Locations Boston Children's Hospital — Boston, Massachusetts, United States View Trial Details
Active, Not Recruiting Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1 NCT05677594 Conditions Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease, +26 more Locations Johns Hopkins University — Baltimore, Maryland, United States View Trial Details
Active, Not Recruiting Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1 NCT03820778 Conditions Atypical Neurofibroma, Atypical Neurofibromatosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +21 more Locations Children's National Health System — Washington D.C., District of Columbia, United States View Trial Details
